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ABSTRACT
Phenotypically identical human hematopoietic stem/progenitor cells (HSC) isolated and characterized based upon specific patterns of CD34 and CD38 expression were found to be functionally heterogeneous, raising the possibility that reversible expression of these antigens occurs during cellular activation and/or proliferation. In these studies, we combined PKH67 tracking with CD34/CD38 immunostaining to compare cell division kinetics between human bone marrow (BM) and cord blood (CB)-derived HSC expanded in a serum-free/stromal-based system for 14 days(d), and correlated CD34 and CD38 expression with the cell divisional history. CB cells began dividing 24h earlier than BM cells, and significantly higher numbers underwent mitosis during the time in culture. By d10, over 55% of the CB-cells reached the 9 th generation, whereas BM-cells were mostly distributed between the 5 th and 7 th generation. By d14, all CB cells had undergone multiple cell divisions, while 0.7-3.8% of BM CD34 + cells remained quiescent. Furthermore, the percentage of BM cells expressing CD34 decreased from 60.8±6.3 to 30.6±6.7% prior to initiating division, suggesting that downmodulation of this antigen occurred before commencement of proliferation.
Moreover, with BM, all primitive CD34 + CD38 -cells present at the end of culture arose from proliferating CD34 + CD38 + cells that downregulated CD38 expression, while in CB, a CD34 + CD38 -population was maintained throughout culture. These studies show that BM and CB cells differ significantly in cell division kinetics and expression of CD34 and CD38, and that the inherent modulation of these antigens during ex vivo expansion may lead to erroneous quantification of the stem cell content of the expanded graft.
INTRODUCTION

Identification and characterization of human hematopoietic stem/progenitor cells (HSC) has
relied upon the detection of specific patterns of antigenic expression such as CD34 (Civin et al., 1984) and CD38 (Breard et al., 1980) . Since seminal studies showed that autologous BM CD34 + cells were able to engraft in baboons (Berenson et al., 1988) and in humans (Berenson et al., 1991) , CD34 expression became the hallmark for selection of human HSC, and CD34 + cells have subsequently been widely used both for human autologous and allogeneic transplantations, resulting in a rapid reconstitution of all blood lineages (Shpall et al., 1994; Stewart et al., 2001) .
While the precise biological role of CD34 is still unknown, functions such as adhesion, homing, proliferation and differentiation have been attributed to this molecule (Baumhueter et al., 1994; Drew et al., 2005; Healy et al., 1995; Lanza et al., 2001; Salati et al., 2008) . Despite these proposed roles, a definite association between CD34 expression and biological function has not thus far been found, and the question remains whether or not all human HSC express CD34 (Dao et al., 2003; Nakamura et al., 2007) . In addition, it was found that CD34 expression by human stem cells is a reversible process, and that CD34 negative cells also contain HSC progenitors with clonogenic potential in vitro and long-term multilineage hematopoietic reconstitution ability in vivo (McKenzie et al., 2007; Tajima et al., 2001; Zanjani et al., 1998; Zanjani et al., 2003) . This apparent controversy regarding the presence or absence of CD34 on HSC has been explained by the assumption that CD34 expression reflects activation, growth commencement, and/or cycling state of the primitive cells (Dooley et al., 2004; McKenzie et al., 2007; Sato et al., 1999) . Thus, these collective findings have not precluded the clinical use of CD34 + cells in HSC transplantation, but rather, have initiated a series of studies aimed at correlating CD34 modulation with stem cell function.
In addition to CD34, another marker that has been associated with stem cell differentiation and growth enhancement (Deaglio et al., 2002; Zocchi et al., 1998) , CD38, has also been linked to regulation of cell cycle and/or proliferation, with quiescent HSC increasing CD38 expression prior to entry into cell cycle (Dooley et al., 2004; McKenzie et al., 2007; Tajima et al., 2001) . These patterns of expression and activation of CD34 and CD38 have now been shown to occur similarly in HSC from a variety of sources, including bone marrow (Tajima et al., 2001) , cord blood (McKenzie et al., 2007) , and mobilized peripheral blood (Dooley et al., 2004) . However, a direct comparison between proliferative responses (i.e. cell division) and patterns of expression of CD34 and CD38 amongst different HSC sources during in vitro expansion has not yet been described. Since important functional differences have been demonstrated between CB, BM, and mobilized PB HSC (Hao et al., 1995; Holyoake et al., 1999; Theunissen and Verfaillie, 2005) , the understanding of the type, frequency, and maturation status of dividing HSC from each cell source could help defining strategies in stem cell expansion, optimize graft composition and determine a window during which HSC are suitable for targeting with gene therapy (Luens et al., 1998; Traycoff et al., 1995) .
In these studies, we combined cell tracking with the membrane dye PKH67 and immunostaining for CD34 and CD38 antigens to characterize the differences in the cell division kinetics of CD34 + enriched cells from BM and CB cultured in a serum-free stromal-based culture system (da Silva et al., 2005) culture. These studies may have significant implications in the quantification of the stem cell content in hematopoietic grafts to be used in a transplant setting.
MATERIAL AND METHODS
Human donor cell preparation. Heparinized human bone marrow (BM) was obtained from healthy donors after informed consent, according to guidelines from the Office of Human Research
Protection at the University of Nevada, Reno. Umbilical cord blood (CB) samples were a kind gift of
Crioestaminal -Saúde e Tecnologia, S.A., (Cantanhede, Portugal). After obtaining maternal donor consent, fresh blood that was going to be discarded was collected from the umbilical cord vein using the method previously described (Chrysler GR, 2004 were magnetically sorted based on Stro-1 positivity as previously described (Gonçalves et al., 2006) . backbone that bind irreversibly to the lipid layer of cell membrane (Huang et al., 1999) . Since the dye is stably incorporated in the cell membrane, the molecules are equally distributed between daughter cells during cell division; each generation of cells is therefore half as fluorescent as the previous one allowing the determination of both the time point at which cultured cells commence cell division and precise quantitation of the number of divisions the cells have undergone at any point in culture (Almeida-Porada et al., 2000; Brandt et al., 1999; Huang et al., 1999) . CD34 + enriched cells labeled with PKH67 were cultured in T-25 flasks (5 ml) for 14 days in QBSF-60 serum free medium (Quality Biological, Gaithersburg, MD, USA) over irradiated human stromal layers with the following cytokines: stem cell factor (SCF) (100 ng/ml), basic-fibroblast growth factor (bFGF) (5 ng/ml), leukemia inhibitory factor (LIF) (10 U/ml) (Leinco Technologies, Inc. St. Louis, MO) and Fms-like tyrosine kinase 3 ligand (Flt-3) (100 ng/ml) (Peprotech, Rocky
Hill, NJ, USA). Cell sampling was performed daily throughout the culture period; cultures were fed every 2-3 days by adjusting to initial volume (5 ml) with fresh medium in order to compensate for the volume harvested with daily cell sampling.
Evaluation of proliferation and phenotypic analysis.
Cultures were evaluated for cell numbers and viability by using Trypan Blue Stain 0.4% solution (GibcoBRL). Cells were analyzed by flow cytometry for stem/progenitor cell content using monoclonal antibodies against CD34 and CD38
(Becton Dickinson Immunocytometry Systems, San Jose, CA), as well as PKH dye fluorescence intensity as previously described (Almeida-Porada et al., 2000; Brandt et al., 1999; Huang et al., 1999 ) cell populations were identified by differences in PKH dye fluorescence intensity, and analyzed for CD34 and CD38 expression by a multiple gating strategy using the CellQuest software (Becton Dickinson).
Study of Cell Proliferation by analysis of FACS data using ModFit software. FACS data were
analyzed using the Proliferation Wizard module of the ModFit software (Becton Dickinson), since it allows the determination of the number of cellular generations in culture. This program is based on histograms of fluorescence intensity and applies deconvolution algorithms to determine the proportion of proliferating cells at each cell division (Givan et al., 1999) . The standard options were chosen to perform analysis on the gated population based on forward-scatter and side-scatter properties (Liu et al., 2006) . The Generation Number was set at 9. For each experiment, the Parent Generation was set as the median fluorescent intensity using the respective sample for day 0. 
RESULTS
BM and CB cells exhibit distinctive divisional histories in vitro.
We have previously described a human stromal-based serum free culture system that allows the By day 2 of culture ( Figure 3B ), 36±8% of CB cells had already reached generation 2, and by day 3 ( Figure 3C ) 42.2±5.2% had reached the 3 rd and 9.3±4.3% the 4 th generation. By contrast, most of the BM cells by day 2 still belonged to Generation 1, and by day 3, 38.2±7.6% of BM cells continued to be in the first generation. While 23.1±7.6% of BM cells had reached Generation 2, and 36.9±19.0%
were in Generation 3, almost none had reached Generation 4 (<1%) by day 3. At day 4, the percentage of cells in CB that had reached the 5 th generation was 15.0±8.7%, whereas only 2.2±0.8%
had reached this generation in BM cultures ( Figure 3D ). Furthermore, at this time point, 3.6±2.6 and 3.7±2.8% of the CB cells had already reached Generations 6 and 7, respectively. The differences in kinetics of division between BM and CB cells were even more pronounced at day 8 ( Figure 3F ), when almost no CB cells remained undivided (less than 0.08% of cells belonging to Parent Generation) and more than 24.3±9.2% had already reached the 9 th generation. By contrast, at this same time point, most of the BM cells were only distributed between the 5 th and 6 th generation, 32.0±2.3 and 38.2±12.0%, respectively. At day 10 ( Figure 3G ), no CB cells remained undivided and more than 56.0±5.6% had reached the 9 th generation, whereas for BM cells, less than 5% had attained Generation 8, and most of the cells were still in generation 6 (47±1.8%) with a smaller percentage being in Generation 7 (25±1.4%). 
BM and CB cultures display different modulation of CD34 + prior to/during initiation of cell division
We next evaluated the correlation between cell division and expression of the CD34 antigen. As previously referred to, Figure Figure 4A and 4B, respectively. While BM cells did not divide significantly between day 0 and 2 (as depicted above), the percentage of BM cells expressing CD34 decreased from 60.8±6.3% at day 0 to 30.6±6.7% at day 2 (p < 0.05) (n=4).
Furthermore, analysis of the CD34 global mean fluorescence intensity in BM cells showed a decrease from 63.0±4.5 at day 0 to 57.4±4.2 at day 2 (Table 1) . By day 3, after cell division had occurred, the total percentage of cells expressing CD34 increased to almost 50%, with 27.3±7.8% and 22.3±7.0% of the cells being positive for CD34 + in the non-divided and in the divided cell fraction, respectively ( Figure 4A ). This data suggests that there is down-regulation of expression of CD34 in BM cells prior to initiation of cell division. By contrast, in CB, the total percentage of cells expressing CD34 remained relatively constant during the first days of culture ( Figure 4B ). At day 0, 90.6±2.14% of CB cells expressed CD34, and at day 2, 68.1±7.0% of the cells in the undivided fraction and 17.3±6.5% in the divided fraction expressed CD34 + (n=4).
Furthermore, since CD34 global mean fluorescent intensity in CB cells showed a significant increase from day 0 (129±21.3) to day 2 (228±61.7), it is possible that CB cell expression of CD34 was upregulated during the first 2 days of culture (Table 1) .
Global mean intensity of CD34 expression decreased progressively with time in culture as CB and BM cells divided; however, after 8 days in culture, the remaining BM and CB CD34 + cells maintained their CD34 global mean intensity until the end of culture (Table 1 ).
Of note is that after 14 days, 2.0±1.3% of the total BM CD34 + population had remained quiescent, never dividing throughout the entire culture period ( Figure 4A ), whereas during the same period of time all of the CB CD34 + cells had undergone cell division ( Figure 4B ).
Differential CD38 expression during division of CD34 + cells in BM and CB cultures
Having established the dynamics of CD34 expression during expansion of CB-and BM-derived cells in culture, we next evaluated differences in CD38 expression of the CD34 + fraction from these two cell sources during the 14-day culture period. The results of these experiments are summarized in 
DISCUSSION
In the present studies, we combined PKH67 tracking with CD34/CD38 immunostaining to compare cell division kinetics between human bone marrow (BM) and cord blood (CB)-derived HSC and correlated CD34 and CD38 expression with the cell divisional history. Published studies using light and phase-contrast microscopy demonstrated that there is no significant difference in cell morphology between PKH-labeled and unlabeled HSC from fetal liver, BM and CB (Huang et al., 1999) , and that PKH staining does not adversely affect early and late progenitor cell function (Traycoff et al., 1995; Young et al., 1996) . In agreement with these prior reports, herein, BM and CB CD34 + enriched cells that were labeled with PKH were expanded with equal efficiency and behaviorally indistinguishable from their unlabeled counterparts that we studied in detail previously (da Silva et al., 2005; Gonçalves et al., 2006) , thus verifying that the results obtained in these studies
were not influenced by PKH labeling. In addition, in order to accurately determine the appropriate threshold beyond which the decrease observed in PKH intensity corresponded to true cell division, we used a non-parametric statistical analysis based on flow cytometry data generated by the Proliferation Wizard of ModFit software. We found that at day 0, before CB and BM cultures were initiated, a negligible percentage of cells were located at the peak intensity for the 2 nd -3 rd generation ( Figure 3A) , due perhaps to either the slightly less than 100% labeling efficiency of those cells, or dilution of the PKH labeling as a result of dye leaking to the feeder cells. Nevertheless, throughout the remainder of the time in culture, ModFit software fitted the data into clearly visible peaks corresponding to cellular division numbers. We found that HSC derived from CB started cell division before day 2 of the culture, with a statistically significant decrease (p <0.05) in the percentage of undivided cells within this time interval, and that BM cells only started intense cell division between days 2 and 3 of culture. CB continued to divide rapidly during the time in culture, such that by day 10, no CB cells remained undivided, and more than 56±5.6% had reached the 9 th generation, whereas for BM cells, less than 5% had attained Generation 8, and most of the cells (47±1.8%) were still in Generation 6. Our results are in agreement with other studies that compared BM and CB derived HSC and showed that the latter exhibit a higher proliferation and expansion potential, possibly due to their ability to exit more rapidly from G 0 -G 1 , (Mayani and Lansdorp, 1998; Traycoff et al., 1994) and/or autocrine production of hematopoietic cytokines (Schibler et al., 1994; Watari et al., 1994) . Alternatively, the functional disparity seen between BM and CB HSC could be attributed to the longer telomere length seen in CB cells, which may correlate with higher replicative capacity (Lansdorp, 1995a; Lansdorp, 1995b; Vaziri et al., 1994) Since we have shown that all the CB-derived cells underwent at least one cell division in the first week of culture of culture while only a small percentage of the BM-derived HSC underwent division during the same period of time, and even those cells that did cycle, the turnover was slower, these results have important implications for HSC-based gene therapy strategies. They suggest that HSC derived from CB could be more efficiently transduced with viral vectors requiring mitosis for genomic integration. Our results are thus consistent with, and provide a possible explanation for, the findings of Moritz and collaborators (Moritz et al., 1993) In agreement with our findings of CD34 downmodulation by BM CD34 + cells are studies by Dooley et al., in which the authors reported that PB-derived CD34 + cells lost CD34 expression while in a quiescent state for 2-3 days, only to begin re-expressing CD34 upon initiation of growth (Dooley et al., 2004) . This up-and downmodulation of CD34 expression may explain the results found by numerous groups showing that BM CD34 -cells contain stem cell potential (Bhatia et al., 1998; Dao et al., 2003; Osawa et al., 1996; Zanjani et al., 1998) . It is possible that at a specific point in culture, a certain percentage of BM HSC will downregulate CD34, thus reducing CD34-mediated aggregation and allowing the cells to enter a phase of cycling (Bullock et al., 2007) . Thus, cells harvested at that specific stage will contribute to the CD34-fraction with stem cell properties.
Furthermore, since Salati et al showed that CD34 silencing enhanced HSC differentiation into the granulocytic and megakaryocytic pathways while reducing erythroid maturation (Salati et al., 2008) under the same culture conditions not only exhibited multilineage clonogenic potential, but they were also able to engraft fetal sheep (Gonçalves et al., 2006) . Thus, we feel it is highly likely that at least some of the CD34 + CD38 -generated from CD34 + CD38 + cells in the present study possessed stem cell-like activity.
Our studies have highlighted the functional differences that exist between CB and BM HSC and added insight into the heterogeneity that exists within HSC populations harboring the same CD34
and/or CD38 phenotype. Since these markers are frequently used to quantify the absolute numbers of stem cells present in hematopoietic grafts prior to transplant and/or assess the number of stem cells obtained after ex-vivo expansion, it is important to realize the limitations of the use of these markers as the sole means of stem cell enumeration and how they change depending on the ontogenic source of the hematopoietic cells. (BM: n=3; CB: n=3).
ACKNOWLEDGMENTS:
